Dorset CCG published a commissioning statement about Freestyle Libre sensors in November 2015, which was updated in December 2017 following a review by the Diabetes Working Group, the Dorset Medicines Advisory Group, and approval by the CCG’s Clinical Commissioning Committee.

This is available from the pan-Dorset Formulary, a publicly available website. Please follow this link to see the Formulary status and click on the PDF document entitled Commissioning Statement on the Use of Freestyle Libre Sensors.

In summary, in line with evidence received so far, NHS Dorset CCG continues to not support the NHS prescribing of this product until a full cost and clinical effectiveness review is available or further national guidance, such as NICE technology appraisal is issued.